AUS
NZ
UK
CA
USA
IND
Healthcare
Two Health Care Stocks: OPT- new market darling, PME- Founder Sell down.
September 10, 2019 04:08 PM AEST| By Team Kalkine MediaAmidst global trade concerns and lower interest rate environment, investors are turning their investments into equity market. With Australia?s equity market offering decent returns, one sector that has garnered significant investor traction is health...
Updates from Five Stocks in Healthcare domain – AGH, BOT, NEU, CYP, ALC
September 10, 2019 01:49 PM AEST| By Team Kalkine MediaHealthcare Sector of Australia Australia is said to have one of the best healthcare systems in the world, with respect to cost, quality and access to healthcare services. The sector, however, faces challenges arising from rising chronic diseases, ag...
What’s Up With These Penny Stocks In Healthcare Space -SIG, PCK, MDR and OSP
September 06, 2019 11:45 PM AEST| By Team Kalkine MediaPenny Stocks are the stocks belonging to small companies. These Stocks trades at less than $ 1 on ASX. In the US markets, these are also referred as micro-cap or nano-cap stocks. The Australian Securities and Investments Commission (ASIC) governs pen...
Remarkable Year-to-Date Return of 2 Australian Biotech Stocks – OPT, IHL
September 06, 2019 10:51 PM AEST| By Team Kalkine MediaMidst diverse sectors, the Australian Biotech sector represents a profitable market with great prospects for considerable returns to investors, fetching their attention to investing in shares despite the fluctuating and uncertain global trend. In Aus...
Australian Cannabis players’ global footprint - Creso Pharma and AusCann Group
September 05, 2019 05:12 PM AEST| By Team Kalkine MediaWith its stock market welcoming investors from across the globe, driven by the rapid domestic acceptance on cannabinoid-based medicines, Australia has proven to be a lucrative hub for the flourishing global cannabis industry, with it being tagged as...
Unfolding the latest Developments in 3 Health Care Stocks- OVN, SPL and MSB
September 05, 2019 01:05 PM AEST| By Team Kalkine MediaOne of the best in the world, Australian health care sector is unceasingly advancing technologies to deliver the best health care services. Despite, a few uncertainties, health care sector caught investors? attention to invest in leading biotechnolog...
Oro-Mucosal Drug Delivery Leader, SUDA Pharmaceuticals Releases Preliminary Final Report
September 04, 2019 09:24 PM AEST| By Team Kalkine MediaDrugs intake in the form of pills, capsules, and tablets are not the most efficient ways of taking medicine, because only about 25% of the drug reaches where it should. Several factors including food affect, enzymatic degradation, drug metabolism, an...
Immuno-Oncology Market Player, Imugene Delivers Remarkable Performance In FY 2019
September 03, 2019 05:56 PM AEST| By Team Kalkine MediaClinical stage immuno-oncology firm headquartered in Australia, Imugene Limited (ASX: IMU) is engaged in the development of a wide range of new treatments that attempt to activate the cancer patients? immune system to detect and remove tumours. Imuge...
Can Healthcare stocks make your life better?
September 03, 2019 03:05 PM AEST| By Team Kalkine MediaAmidst global trade worries and lower bond returns, investors are flocking to equity market. One such sector gaining interests of market players is Healthcare sector comprising. The sector represents ample lucrative stocks with strong growth prospect...
Noxopharm Unveils Further Promising Results: Veyonda® Enhances Radiotherapy in Prostate Cancer Treatment
September 03, 2019 01:32 PM AEST| By Team Kalkine MediaNoxopharm Limited (ASX: NOX) is an Australian clinical-stage drug development company, which recently marked its third anniversary on the Australian Securities Exchange since its listing in August 2016. The company is primarily focused on the develop...
Latest With Healthcare Players In Penny Space - EX1, OVN, BD1, OSL
August 31, 2019 08:15 AM AEST| By Team Kalkine MediaThe science of Regenerative Medicine is a rapidly emerging field linking the medical technology, biotechnology and pharmaceutical sectors, and holds much potential to deliver better patient outcomes and drive economic growth.? Regenerative Medicine T...
2 Most Important Things To Consider When Looking At Health Care Stocks – RHC, BIT, PAR
August 30, 2019 11:57 PM AEST| By Team Kalkine MediaAustralia has a robust health care system, jointly operated by the federal, state and local governments, and is labeled as one of the best in the world. For investors, health care stands among the top few sectors, and is the safest sectors in Austral...
An Eye On Latest Updates On Three Health Care Stocks: SPL, TLX, PBP
August 30, 2019 02:45 PM AEST| By Team Kalkine MediaThe benchmark Index S&P/ASX 200 settled at 6,604.2 on 30 August 2019, up 96.8 points or 1.47% from its previous close, while S&P/ASX 200 Health Care (Sector) inched up 674 points or 1.83% to settle at 36,822.2. Below discussed are three compa...
Why should you consider investing in Cortical Dynamics? Cortical Dynamics’ Funding Offer
August 30, 2019 02:22 PM AEST| By Team Kalkine MediaToo much anaesthesia leads to post-operative complications, longer hospital stays and severe conditions like PTSD. It is estimated that 37-46% of surgical patients are affected by postoperative Delirium (a serious disturbance in mental abilities). In...
SUDA Pharmaceuticals Reformulating Billion-Dollar Drugs for Oral Delivery
August 30, 2019 12:58 PM AEST| By Team Kalkine MediaAustralia?s leading oro-mucosal drug delivery company, SUDA Pharmaceuticals Ltd (ASX: SUD) produces reliable oral sprays by using its proprietary OroMist? technology to redevelop the ex-blockbuster drugs. SUDA?s low-risk oral sprays possess the abili...
Catch Up On Five Healthcare Stocks- NAN, PME, HLS, MSB, CTE
August 28, 2019 05:13 PM AEST| By Team Kalkine MediaAs per Australia?s Budget for 2019-20, the total Commonwealth health spending is likely to grow from $81.8 billion in 2019-20 to $89.5 billion in 2022-23. This bright outlook cements that fact that the Australian healthcare sector is one of the best...
Zooming Lens on Neuren’s Drug Candidate, NNZ-2591
August 27, 2019 01:10 PM AEST| By Team Kalkine MediaAustralian-headquartered biopharmaceutical company, Neuren Pharmaceuticals Limited (ASX: NEU) develops a range of novel therapies for treating neurodevelopmental disorders with a high unmet medical need, using artificial analogs of neurotrophic pepti...
ResApp Health Acquires CE Mark Certification For World’s First Smartphone-Based Tool For Acute Respiratory Disease
August 26, 2019 10:02 PM AEST| By Team Kalkine MediaResApp Health Limited (ASX: RAP), is a prime healthcare company headquartered in Brisbane, Australia that creates clinically validated, regulatory-cleared, smartphone applications based digital tools to diagnose and manage acute respiratory diseases....
What’s brewing up in Pharmaceutical space: MYX, MXC, CGB, OSL
August 26, 2019 06:57 PM AEST| By Team Kalkine MediaDuring the ongoing Earnings season, few pharma companies have reported decent sets of numbers, while most of the companies have posted quarterly loss added by higher R&D costs and higher capital expenditure due to establishment of new facilities....
Noxopharm pre-clinical evidence confirms Veyonda® abscopal effect; NOX completes three years on ASX
August 26, 2019 02:37 PM AEST| By Team Kalkine MediaOn 21 August 2019, clinical-stage drug development company Noxopharm Limited (ASX: NOX) pre-clinical evidence confirmed that its lead drug candidate Veyonda® has the potential to produce off-target responses known as an abscopal effect. The comp...
Advertise your brand on Kalkine Media